## Abstract CD44 is a glycosylated adhesion molecule and osteopontin is one of its ligand. CD44 undergoes alternative splicing to produce variant isoforms. Our recent studies have shown an increase in the surface expression of CD44 isoforms (sCD44 and v4βv10 variant CD44) in prostate cancer cells o
Expression of CD44 in prostate cancer cells
β Scribed by Liu, Alvin Y.
- Book ID
- 122946543
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 851 KB
- Volume
- 76
- Category
- Article
- ISSN
- 0304-3835
No coin nor oath required. For personal study only.
π SIMILAR VOLUMES
Decreased expression of CD44 is an independent prognostic marker for surgically treated prostate cancer. To investigate immunohistochemically defined CD44 expression in primary and metastatic prostate cancer, 2 groups of patients undergoing radical prostatectomy for clinically localized prostate can
We have examined the expression of the transmembrane glycoproteins CD44 in four human prostate tumor cell lines. Expression was examined at the protein level by flow cytometric analysis and Western blot, and at the mRNA level by reverse transcriptionpolymerase chain reaction (RT-PCR). All four cell